Report scope & Overview:
The Medical Marijuana Market size was valued at USD 6.80 Bn in 2022 and is expected to reach USD 32.50 Bn by 2030, with a CAGR of 21.60% over the forecast period of 2023-2030.
The use of the cannabis plant or its cannabinoids for therapeutic purposes under the guidance of a healthcare practitioner is referred to as medical marijuana, also known as medical cannabis. Cannabinoids including delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), which may be useful medically, are among the active substances found in cannabis. In relation to medical marijuana, keep in mind the following Applications in medicine: Medical marijuana is used to manage a variety of illnesses and symptoms. It has been investigated for its potential to treat neurological problems, as well as pain, nausea, muscle spasms, and inflammation. Chronic pain, multiple sclerosis, epilepsy, chemotherapy-induced nausea and vomiting, and some forms of neuropathic pain are among the illnesses for which medical marijuana is frequently prescribed. THC, the cannabinoid that gives cannabis its psychoactive effects, is also the substance that gives CBD its non-psychoactive properties and possible therapeutic uses. THC to CBD ratios in medical marijuana might differ between strains and preparations. Administration: There are several different ways to consume medical marijuana, including smoking, vaping, eating edibles, using tinctures, using topical treatments, or taking oral capsules. The method of administration is determined by the ailment being treated and the patient's preferences.
There are significant regional, national, and local differences in the legality of medical marijuana. While some locations have tight prohibitions, others have legalised medical marijuana for specific medical ailments. Patients frequently require a prescription or recommendation from a licenced healthcare provider in states where medicinal marijuana is permitted. Who is eligible for medicinal marijuana and how it is obtained may be subject to different regulations. While there is evidence to support the use of cannabis for some medical diseases, additional high-quality research is required to determine the effectiveness and safety of cannabis use for a variety of medical disorders. Common medicinal marijuana side effects may include tiredness, dry mouth, decreased motor coordination, and mood swings.
Rise in the patient demand
People who struggle with chronic pain, incapacitating symptoms, or ailments that do not respond well to standard medical care may turn to alternative remedies like medicinal marijuana. Demand from patients has been a key factor in the fight for legalisation and accessibility.
The legal restrictions
THC and CBD, two cannabinoids found in cannabis, have the potential to provide a range of health advantages. According to research, medical marijuana may help treat and manage illnesses like chronic pain, nausea, muscle spasms, epilepsy, and some neurological disorders by reducing their symptoms. Advocates, patients, and medical experts have all sought to spread the word about the potential advantages of medicinal marijuana. Campaigns for education have helped to alter popular opinions and lessen the stigma attached to its usage.
The access element for the patients
Impact of Recession
If the price becomes an issue, patients can look into alternative therapies or cut back on their medicinal marijuana usage. They might also look for cheaper options, which could hurt sales of expensive goods. Disruptions in the supply chain: The availability of medical marijuana products may be impacted by supply chain, manufacturing, and distribution problems brought on by the recession. Lack of supply could have an influence on patients' access to their prescribed medications. Alterations to the Regulatory Environment: During economic downturns, governments may reevaluate their priorities, particularly those related to healthcare and drug regulation. This might result in modifications to laws governing the cultivation, transfer, and sale of medical marijuana.
Impact of Russia Ukraine War
Lack of resources, particularly those necessary for the growth and manufacturing of medical marijuana, can result from conflict. This could lead to higher prices and a reduction in the supply of medical marijuana products. Collaboration between nations is more challenging when there are geopolitical tensions in the interactions between nations. This might have an effect on how medical marijuana knowledge, technology, and expertise are shared. Public Perception and Stigma: The media portrayal of the dispute may have an impact on the public's perceptions of and attitudes towards a variety of topics, including medical marijuana. The perception of goods coming from certain conflict-affected nations may be indirectly impacted by negative portrayals of those nations.
By Product Type
Oil & Tinctures
Rest of Eastern Europe
Rest of Western Europe
Rest of Asia Pacific
Middle East & Africa
Rest of Middle East
Rest of Africa
Rest of Latin America
The major key players are Tilray, Aurora Cannabis, Aphria, Maricann, Tikun Olam, MedReleaf, GW Pharmaceuticals, Cannabis Sativa, Medical Marijuana.
Aurora Cannabis-Company Financial Analysis
North America region will be the region with the highest share in terms of value because varied degrees, medical marijuana is now legal in many U.S. states. It remains a Schedule I controlled substance under federal law, which poses some legal and administrative difficulties. While some states have comprehensive medical marijuana policies, others have more stringent ones. Both medical and recreational marijuana are now legal in Canada. The medicinal marijuana market was well-established, and authorised producers offered patients a range of goods.
A growing number of patients were able to obtain medicinal cannabis with prescriptions in Germany, which has one of the most sophisticated medical marijuana programmes in all of Europe. Despite being recognised for its lax drug laws, the Netherlands maintains a modest and strictly controlled medical marijuana industry. In 2018, the UK legalised medical cannabis, but due to regulatory restrictions and healthcare professionals' resistance, access remained restricted.
|Market Size in 2022
|US$ 6.80 Bn
|Market Size by 2030
|US$ 32.50 Bn
|CAGR of 21.60 % From 2023 to 2030
|Report Scope & Coverage
|Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
|• By Product Type (Flower, Oil & Tinctures)
• By Application (Chronic Pain, Arthritis, Migraine, Cancer, Diabetes, AIDS, Epilepsy, Others)
|North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America)
|Tilray, Aurora Cannabis, Aphria, Maricann, Tikun Olam, MedReleaf, GW Pharmaceuticals, Cannabis Sativa, Medical Marijuana.
|• Rise in the patient demand
|• The legal restrictions
Ans. The Compound Annual Growth rate for Medical Marijuana Market over the forecast period is 21.60%.
Ans. USD 13.60 Billion is the projected Medical Marijuana market size of market by 2030.
Ans. The major key players are Tilray, Aurora Cannabis, Aphria, Maricann, Tikun Olam, MedReleaf, GW Pharmaceuticals, Cannabis Sativa, Medical Marijuana.
Ans. North America is the fastest growing region of the Medical Marijuana Market.
Ans. The legal restrictions and the access element for the patients.
TABLE OF CONTENT
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 Impact of the Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.2 Impact on major economies
126.96.36.199 United Kingdom
188.8.131.52 South Korea
184.108.40.206 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Medical Marijuana Market Segmentation, by Product Type
8.2 Oil & Tinctures
9. Medical Marijuana Market Segmentation, by Application
9.1 Chronic Pain
10. Regional Analysis
10.2 North America
10.2.1 North America Medical Marijuana Market by Country
10.2.2 North America Medical Marijuana Market by Product Type
10.2.3 North America Medical Marijuana Market by Application
10.2.4.1 USA Medical Marijuana Market by Product Type
10.2.4.2 USA Medical Marijuana Market by Application
10.2.5.1 Canada Medical Marijuana Market by Product Type
10.2.5.2 Canada Medical Marijuana Market by Application
10.2.6.1 Mexico Medical Marijuana Market by Raw Technology
10.2.6.2 Mexico Medical Marijuana Market by Application
10.3.1 Eastern Europe
10.3.1.1 Eastern Europe Medical Marijuana Market by Country
10.3.1.2 Eastern Europe Medical Marijuana Market by Product Type
10.3.1.3 Eastern Europe Medical Marijuana Market by Application
10.3.1.4.1 Poland Medical Marijuana Market by Product Type
10.3.1.4.2 Poland Medical Marijuana Market by Application
10.3.1.5.1 Romania Medical Marijuana Market by Product Type
10.3.1.5.2 Romania Medical Marijuana Market by Application
10.3.1.6.1 Hungary Medical Marijuana Market by Product Type
10.3.1.6.2 Hungary Medical Marijuana Market by Application
10.3.1.7.1 Turkey Medical Marijuana Market by Product Type
10.3.1.7.2 Turkey Medical Marijuana Market by Application
10.3.1.8 Rest of Eastern Europe
10.3.1.8.1 Rest of Eastern Europe Medical Marijuana Market by Product Type
10.3.1.8.2 Rest of Eastern Europe Medical Marijuana Market by Application
10.3.2 Western Europe
10.3.2.1 Western Europe Medical Marijuana Market by Country
10.3.2.2 Western Europe Medical Marijuana Market by Product Type
10.3.2.3 Western Europe Medical Marijuana Market by Application
10.3.2.4.1 Germany Medical Marijuana Market by Product Type
10.3.2.4.2 Germany Medical Marijuana Market by Application
10.3.2.5.1 France Medical Marijuana Market by Product Type
10.3.2.5.2 France Medical Marijuana Market by Application
10.3.2.6.1 UK Medical Marijuana Market by Product Type
10.3.2.6.2 UK Medical Marijuana Market by Application
10.3.2.7.1 Italy Medical Marijuana Market by Product Type
10.3.2.7.2 Italy Medical Marijuana Market by Application
10.3.2.8.1 Spain Medical Marijuana Market by Product Type
10.3.2.8.2 Spain Medical Marijuana Market by Application
10.3.2.9.1 Netherlands Medical Marijuana Market by Product Type
10.3.2.9.2 Netherlands Medical Marijuana Market by Application
10.3.2.10.1 Switzerland Medical Marijuana Market by Product Type
10.3.2.10.2 Switzerland Medical Marijuana Market by Application
10.3.2.11.1 Austria Medical Marijuana Market by Product Type
10.3.2.11.2 Austria Medical Marijuana Market by Application
10.3.2.12 Rest of Western Europe
10.3.2.12.1 Rest of Western Europe Medical Marijuana Market by Product Type
10.3.2.12.2 Rest of Western Europe Medical Marijuana Market by Application
10.4.1 Asia Pacific Medical Marijuana Market by Country
10.4.2 Asia Pacific Medical Marijuana Market by Product Type
10.4.3 Asia Pacific Medical Marijuana Market by Application
10.4.4.1 China Medical Marijuana Market by Product Type
10.4.4.2 China Medical Marijuana Market by Application
10.4.5.1 India Medical Marijuana Market by Product Type
10.4.5.2 India Medical Marijuana Market by Application
10.4.6.1 Japan Medical Marijuana Market by Product Type
10.4.6.2 Japan Medical Marijuana Market by Application
10.4.7 South Korea
10.4.7.1 South Korea Medical Marijuana Market by Product Type
10.4.7.2 South Korea Medical Marijuana Market by Application
10.4.8.1 Vietnam Medical Marijuana Market by Product Type
10.4.8.2 Vietnam Medical Marijuana Market by Application
10.4.9.1 Singapore Medical Marijuana Market by Product Type
10.4.9.2 Singapore Medical Marijuana Market by Application
10.4.10.1 Australia Medical Marijuana Market by Product Type
10.4.10.2 Australia Medical Marijuana Market by Application
10.4.11 Rest of Asia-Pacific
10.4.11.1 Rest of Asia-Pacific Medical Marijuana Market by Product Type
10.4.11.2 Rest of Asia-Pacific Medical Marijuana Market by Application
10.5 Middle East & Africa
10.5.1 Middle East
10.5.1.1 Middle East Medical Marijuana Market by Country
10.5.1.2 Middle East Medical Marijuana Market by Product Type
10.5.1.3 Middle East Medical Marijuana Market by Application
10.5.1.4.1 UAE Medical Marijuana Market by Product Type
10.5.1.4.2 UAE Medical Marijuana Market by Application
10.5.1.5.1 Egypt Medical Marijuana Market by Product Type
10.5.1.5.2 Egypt Medical Marijuana Market by Application
10.5.1.6 Saudi Arabia
10.5.1.6.1 Saudi Arabia Medical Marijuana Market by Product Type
10.5.1.6.2 Saudi Arabia Medical Marijuana Market by Application
10.5.1.7.1 Qatar Medical Marijuana Market by Product Type
10.5.1.7.2 Qatar Medical Marijuana Market by Application
10.5.1.8 Rest of Middle East
10.5.1.8.1 Rest of Middle East Medical Marijuana Market by Product Type
10.5.1.8.2 Rest of Middle East Medical Marijuana Market by Application
10.5.2.1 Africa Medical Marijuana Market by Country
10.5.2.2 Africa Medical Marijuana Market by Product Type
10.5.2.3 Africa Medical Marijuana Market by Application
10.5.2.4.1 Nigeria Medical Marijuana Market by Product Type
10.5.2.4.2 Nigeria Medical Marijuana Market by Application
10.5.2.5 South Africa
10.5.2.5.1 South Africa Medical Marijuana Market by Product Type
10.5.2.5.2 South Africa Medical Marijuana Market by Application
10.5.2.6 Rest of Africa
10.5.2.6.1 Rest of Africa Medical Marijuana Market by Product Type
10.5.2.6.2 Rest of Africa Medical Marijuana Market by Application
10.6 Latin America
10.6.1 Latin America Medical Marijuana Market by Country
10.6.2 Latin America Medical Marijuana Market by Product Type
10.6.3 Latin America Medical Marijuana Market by Application
10.6.4.1 Brazil Medical Marijuana Market by Product Type
10.6.4.2 Brazil Medical Marijuana Market by Application
10.6.5.1 Argentina Medical Marijuana Market by Product Type
10.6.5.2 Argentina Medical Marijuana Market by Application
10.6.6.1 Colombia Medical Marijuana Market by Product Type
10.6.6.2 Colombia Medical Marijuana Market by Application
10.6.7 Rest of Latin America
10.6.7.1 Rest of Latin America Medical Marijuana Market by Product Type
10.6.7.2 Rest of Latin America Medical Marijuana Market by Application
11 Company Profile
11.1.1 Company Overview
11.1.3 Product/Services Offered
11.1.4 SWOT Analysis
11.1.5 The SNS View
11.2 Aurora Cannabis
11.2.1 Company Overview
11.2.3 Product/Services Offered
11.2.4 SWOT Analysis
11.2.5 The SNS View
11.3.1 Company Overview
11.3.3 Product/Services Offered
11.3.4 SWOT Analysis
11.3.5 The SNS View
11.4 Company Overview
11.4.3 Product/Services Offered
11.4.4 SWOT Analysis
11.4.5 The SNS View
11.5 Tikun Olam
11.5.1 Company Overview
11.5.3 Product/Services Offered
11.5.4 SWOT Analysis
11.5.5 The SNS View
11.6.1 Company Overview
11.6.3 Product/Services Offered
11.6.4 SWOT Analysis
11.6.5 The SNS View
11.7 GW Pharmaceuticals
11.7.1 Company Overview
11.7.3 Product/Services Offered
11.7.4 SWOT Analysis
11.7.5 The SNS View
11.8 Cannabis Sativa
11.8.1 Company Overview
11.8.3 Product/Services Offered
11.8.4 SWOT Analysis
11.8.5 The SNS View
11.9 Medical Marijuana.
11.9.1 Company Overview
11.9.3 Product/ Services Offered
11.9.4 SWOT Analysis
11.9.5 The SNS View
12. Competitive Landscape
12.1 Competitive Bench marking
12.2 Market Share Analysis
12.3 Recent Developments
12.3.1 Industry News
12.3.2 Company News
12.3.3 Mergers & Acquisitions
13. USE Cases and Best Practices
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Corporate Wellness Market Size was valued at USD 61.11 billion in 2022 and is projected to reach USD 109.81 billion in 2030, with a growing of CAGR of 7.6% during the forecast period 2023-2030.
The Clinical Risk Grouping Solutions Market Size was valued at USD 640 million in 2022, and is expected to reach USD 1890 million by 2030, and grow at a CAGR of 14.5% over the forecast period 2023-2030.
The Mass Spectrometry Market size was estimated at USD 5195.45 million in 2022 and is expected to reach USD 9723.78 million by 2030 at a CAGR of 8.15% during the forecast period of 2023-2030.
In 2022, The Telerehabilitation Market size amounted to USD 3.70 Billion & is estimated to reach USD 11.39 Billion by 2030 and increase at a compound annual growth rate of 15.1% between 2023 and 2030.
The size was valued at USD 448.25 Million in 2022 and is expected to reach USD 618.20 Million By 2030 and grow at a CAGR of 4.1% over the forecast period of 2023-2030.
The Healthcare Quality Management Market Size was valued at USD 3.45 billion in 2022 and is expected to reach USD 10.42 billion by 2030, and grow at a CAGR of 14.8% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone